Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Issuers

FINAL PXG: IQVIA E550m 5NC2 at 1.75%, E900m 8NC3 at 2.25%

HYC European Market: Deal Flow - General

IQVIA Inc (IQV) EUR1.45bn 144A/Reg S sr notes 2-part. Ba3/BB (stable/stable). Via JPM (sole physical books, B&D)/Barc/BofA/GS/HSBC/WFS joint books, Citi, FITB, PNC, Mizuho, MUFG, TD, TSI, BBVA, BNPP, Huntington, RBC, Siebert Willliams as co-managers. No reg rights. List ISE. NY law.

   - EUR550m (from minimum EUR400m) due 2026 (5y). NC2 (MWC B+50bp) (50%,25%,par). Equity claw: 2y 40%. IPT: 2.00%-2.25%. Px talk: 1.75%-1.875%. Final pricing: EUR550m at 1.75%.

   - EUR900m due 2029 (8y). NC3 (MWC B+50bp) (50%,25%,par). Equity claw: 3y 40%. IPT: 2.50% area. Px talk: 2.25%-2.50%. Final pricing: EUR900m at 2.25%.

Did global investor call at 1pm UKT yesterday (virtual 1x1 meetings were also available yesterday). Books closed at 2pm UKT today. Pricing today UK afternoon. UOP: redeem its EUR1.425bn 3.25% sr notes due 03/15/25 (callable at 100.813 on 03/15/21). Biz: leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. HQ: Durham, NC and Danbury, CT.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.